<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04902170</url>
  </required_header>
  <id_info>
    <org_study_id>202008057DIFD</org_study_id>
    <nct_id>NCT04902170</nct_id>
  </id_info>
  <brief_title>Long-shaft Vitrectomy Probe in Highly Myopic Eyes</brief_title>
  <official_title>The Surgical Outcomes of Long-shaft Vitrectomy Probe for Vitreoretinal Diseases in Highly Myopic Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to compare the safety and efficacy of vitrectomy probe with different shaft&#xD;
      lengths in vitreoretinal surgery of highly myopic patients. In this randomized controlled&#xD;
      study, highly myopic patients who had axial length more than 26 mm and needed vitreoretinal&#xD;
      surgery will be enrolled. The enrolled patients will be randomized into &quot;30 mm shaft length&#xD;
      group&quot;(trial group) and &quot;27mm shaft length group&quot;(controlled group). We will compare the rate&#xD;
      of wound leakage, hypotony, subconjunctival hemorrhage, probe bending, trocar removal, and&#xD;
      endophthalmitis between the two groups. We would like to evaluate the efficacy and safety of&#xD;
      the 30 mm shaft length vitrectomy probe.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>trocar removal rate</measure>
    <time_frame>intra-operative</time_frame>
    <description>trocar removal would be performed if the length of vitrectomy probe was not adequate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>operation time</measure>
    <time_frame>intra-operative</time_frame>
    <description>record the operation time and time of core vitrectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>instrument bending</measure>
    <time_frame>intraoperative</time_frame>
    <description>record the occurrence of instrument bending</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Complications</measure>
    <time_frame>Until post-op 6 month</time_frame>
    <description>the presence of vitreous hemorrhage, retinal hemorrhage, retinal detachment, choroidal hemorrhage, endophthalmitis</description>
  </other_outcome>
  <other_outcome>
    <measure>wound status evaluation by slit lamp biomicroscopy</measure>
    <time_frame>until post-op 1 month</time_frame>
    <description>the presence of subconjunctival hemorrhage, chemosis, subconjunctival air, wound suture</description>
  </other_outcome>
  <other_outcome>
    <measure>anatomical success evaluation by optical coherence tomography and indirect ophthalmolscopy</measure>
    <time_frame>post-op 3 month</time_frame>
    <description>whether the disease was successfully treated</description>
  </other_outcome>
  <other_outcome>
    <measure>anatomical success evaluation by optical coherence tomography and indirect ophthalmolscopy</measure>
    <time_frame>post-op 6 month</time_frame>
    <description>whether the disease was successfully treated</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Retinal Diseases</condition>
  <condition>High Myopia</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Highly myopic patients with vitreoretinal disease requiring pars plana vitrectomy. The 30mm (shaft length) vitrectomy probe (25 gauge) would be used in the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Highly myopic patients with vitreoretinal disease requiring pars plana vitrectomy. The 27mm (shaft length) vitrectomy probe (25 gauge) would be used in the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>25 gauge pars plana vitrectomy</intervention_name>
    <description>25 gauge pars plana vitrectomy</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Highly myopic patients (axial length &gt; 26mm) with vitreoretinal diseases or&#xD;
             maculopathy requiring pars plana vitrectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous history of pars plana vitrectomy&#xD;
&#xD;
          -  Surgical plan combining encircling buckle&#xD;
&#xD;
          -  Silicone oil or perfluorocarbon liquid use intraoperatively&#xD;
&#xD;
          -  Previous history of pterygium surgery, trabeculectomy, glaucoma surgery&#xD;
&#xD;
          -  Previous history of corneal, conjunctival, or scleral laceration&#xD;
&#xD;
          -  History of connective tissue disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tzyy-Chang Ho</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tzyy-Chang Ho, MD</last_name>
    <phone>+886-2-23123456</phone>
    <phone_ext>65190</phone_ext>
    <email>hotchang@ntu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yun Hsia, MD</last_name>
    <email>summeryun0812@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tzyy-Chang Ho, MD</last_name>
      <email>hotchang@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 21, 2021</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>High myopia</keyword>
  <keyword>Pars plana vitrectomy</keyword>
  <keyword>Vitreoretinal disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

